Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin. Dias D, Damasio I, Marques P, Simoes H, et al. Eur Thyroid J 2023;12:e220227.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dias D, Damasio I, Marques P, Simoes H, et al. Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin. Eur Thyroid J 2023;12:e220227.
PMID: 36976625